According to an earlier study (Truong et al., 2014), activation of the Keap1-Nrf2 pathway could inhibit the activation of hepatic stellate cells and their production of a large amount of collagen, thus, inhibiting the occurrence and development of liver fibrosis. The gene discussed is NFE2L2; the disease is Hepatic fibrosis.